Eventide Asset Management, LLC 13D and 13G filings for Aura Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 11:56 am Sale | 2024-12-31 | 13G | Aura Biosciences, Inc. AURA | Eventide Asset Management, LLC | 4,080,605 8.170% | -1,722,077 (-29.68%) | Filing |
| 2023-12-11 5:14 pm Purchase | 2023-11-30 | 13G | Aura Biosciences, Inc. AURA | Eventide Asset Management, LLC | 5,802,682 11.820% | 3,551,314 (+157.74%) | Filing |
| 2023-02-14 1:30 pm Purchase | 2022-12-31 | 13G | Aura Biosciences, Inc. AURA | Eventide Asset Management, LLC | 2,251,368 6.300% | 2,251,368 (New Position) | Filing |